Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XILLIX FDA APPROVED -- Ignore unavailable to you. Want to Upgrade?

To: Edward W. Richmond who wrote (281)	6/28/1998 4:58:00 PM
From: marcos	Read Replies (1) \| Respond to of 572

Ed, I found myself underwater with this one again lately, after trading my way out of the hole since first getting in a year or so ago. Had to decide whether to dump/hold/buy, and chose to buy more, with a tentative near-term trading target of 2.45. Have to agree with your comments on Midland analysts overall, but I've followed James Keating of their Financial Services, and put considerable stock in what he says. He's answered every email I've sent him, quickly and candidly, and I've made a lot of money following his advice. Also I find Christine Farkas worth listening to, and Bob Feick of their oilpatch bunch. But there's lots of bad examples, I agree, notably the WIM@5.00-pushers. I figure I'll give this Andr‚ Uddin a chance, though. And this JV with Miravant does look like a good thing, if nothing else it is yet another vote of confidence in xlx technology. But ¨qui‚n sabe? Que ser , ser .